Homebiotech

biotech

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026

biotech

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

Jim Cornall - April 30, 2026

biotech

Aragen launches India’s first women-led chemistry synthesis laboratory

Jim Cornall - April 30, 2026

biotech

Vaccine strategy induces broadly neutralising HIV antibodies

Jim Cornall - April 30, 2026

biotech

Biotech tests in space?

Jim Cornall - August 4, 2025

biotech

Base to Base biotech podcast 20: Terumo BCT boosts CAR-T cell manufacturing, and Orbis on macrocycles

Jim Cornall - August 1, 2025

biotech

Pfizer boosts cancer portfolio with 3SBio licensing agreement

Jim Cornall - July 31, 2025

biotech

Collaboration on AI-powered bioreactors looks to revolutionise biopharma manufacturing

Jim Cornall - July 31, 2025

biotech

Gate Bioscience working with Lilly to discover and develop molecular gate medicines

Jim Cornall - July 31, 2025

biotech

Trial results announced for kidney transplant recipients with BKPyV infection

Jim Cornall - July 30, 2025

biotech

NKGen Biotech and HekaBio partner to introduce NK cell therapy to Japan

Jim Cornall - July 30, 2025

biotech

Spear Bio launches ultra-sensitive immunoassay solution

Jim Cornall - July 30, 2025

1...585960...73 Page 59 of 73

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026 0

This week, our conversations are with Uwe Diegel, CEO of Lifeina, about their cooling technologies, and with Dirk Beher, CEO of FundaMental Pharma, about...

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

biotech Jim Cornall - April 30, 2026 0

Aragen launches India’s first women-led chemistry synthesis laboratory

biotech Jim Cornall - April 30, 2026 0

Vaccine strategy induces broadly neutralising HIV antibodies

biotech Jim Cornall - April 30, 2026 0

New target for cancer treatment

biotech Jim Cornall - April 29, 2026 0